Home | About PM | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Pharmacognosy Magazine
Search Article 
Advanced search 
Year : 2019  |  Volume : 15  |  Issue : 66  |  Page : 426-432

Metabolic Profile Elucidation of Ventilago calyculata Aqueous Extract Attenuating Sequelae of Aspirin Retarded Wound Healing

1 Department of Pharmacy, Pharmacognosy and Pharmacology Laboratory, Faculty of Pharmacy, VNS Group of Institution, Bhopal, Madhya Pradesh, India
2 Department of Pharmacy, Pharmacognosy and Pharmacology Laboratory, Faculty of Pharmacy, VNS Group of Institution; Department of Pharmacy, Truba Institute of Pharmacy, Bhopal, Madhya Pradesh, India
3 Department of Pharmacy, School of Pharmaceutical Sciences, RGPV, Bhopal, Madhya Pradesh, India

Correspondence Address:
Rajesh Singh Pawar
Pharmacognosy and Pharmacology Laboratory, Faculty of Pharmacy, VNS Group of Institution, VNS Campus, Vidya Vihar, Neelbud, Bhopal - 462 044, Madhya Pradesh
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/pm.pm_131_19

Rights and Permissions

Background: Impaired wound healing due to aspirin is a common cause of delay in healing. Ventilago calyculata Tul. (Rhamnaceae) is used extensively in the Indian traditional medicines for skin problems. Objective: The objective of this work was to test the potential of formulations prepared from the extracts of V. calyculata against aspirin-retarded wound healing in rats and investigate the probable mechanism of action. Materials and Methods: The effect of topical administration of fractionates of V. calyculata against aspirin-delayed wound healing was assessed in Wistar albino rats. The chemo-profiling (liquid chromatography-mass spectroscopy [LC-MS]) of the extract with the most potent wound healing activity was carried out. Further, the mechanism of the most potent Ventilago calyculata aqueous extract (VCA) was determined by viability and plasma membrane integrity assays in H2O2-challenged wild type Saccharomyces cerevisiae BY4743) and knock-out strain (Δtrx2) strains. Results: The results of our investigations showed that in excision wound model; all formulations had statistically significant (P < 0.01) wound healing activity compared to the negative control. However, aqueous extract treatment (HF3) exhibited maximum activity, and the chemo-profiling of VCA by LCMS suggested that the potent activity may be due to individual and/or synergistic effect of the identified pharmacologically active phytoconstituents. The study on yeast indicates that VCA was able to act intracellularly also as it was able to overcome the growth inhibitory effect of the H2O2significantly (P < 0.01). Conclusion: We propose that treatment with HF3(VCA) is a therapeutically beneficial method of decelerating wound retardation caused by aspirin intake in patients on long-term aspirin therapy.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded172    
    Comments [Add]    
    Cited by others 1    

Recommend this journal